UK approves bivalent Moderna vaccine targeting Omicron and original SARS-CoV-2
The UK has become the first country to approve a bivalent Moderna vaccine designed to target both the original SARS-CoV-2 strain and the Omicron variant.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthUK approves bivalent Moderna vaccine targeting Omicron and original SARS-CoV-2
Sign in or subscribeBrowse free archive reportsThe UK has become the first country to approve a bivalent Moderna vaccine designed to target both the original SARS-CoV-2 strain and the Omicron variant.